Angel Vazquez-Vizoso
A Coruna, GA 15006, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Circulating lncRNA Landscapes: Redefining Biomarker Discovery in Ovarian Cancer.
Journal: Current medicinal chemistry
Published: April 06, 2026
Correction: Salamini-Montemurri et al. The Challenges and Opportunities of LncRNAs in Ovarian Cancer Research and Clinical Use. Cancers 2020, 12, 1020.
Journal: Cancers
Published: March 24, 2026
Long Non-Coding RNA-Derived Peptides as a Novel Source of Tumor Neoantigens: Expanding the Immunopeptidome Beyond Canonical Coding Regions.
Journal: Biology
Published: February 28, 2026
Ferroptosis: An emerging strategy for managing epithelial ovarian cancer.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 09, 2025
The Effect of HMGB1 and HMGB2 on Transcriptional Regulation Differs in Neuroendocrine and Adenocarcinoma Models of Prostate Cancer.
Journal: International journal of molecular sciences
Published: January 23, 2024
Identification of lncRNAs Deregulated in Epithelial Ovarian Cancer Based on a Gene Expression Profiling Meta-Analysis.
Journal: International journal of molecular sciences
Published: May 15, 2023
Thanksgiving to Yeast, the HMGB Proteins History from Yeast to Cancer.
Journal: Microorganisms
Published: February 28, 2023
Study of Ferroptosis Transmission by Small Extracellular Vesicles in Epithelial Ovarian Cancer Cells.
Journal: Antioxidants (Basel, Switzerland)
Published: December 21, 2022
The HMGB Protein KlIxr1, a DNA Binding Regulator of Kluyveromyces lactis Gene Expression Involved in Oxidative Metabolism, Growth, and dNTP Synthesis.
Journal: Biomolecules
Published: August 14, 2021
The HMGB1-2 Ovarian Cancer Interactome. The Role of HMGB Proteins and Their Interacting Partners MIEN1 and NOP53 in Ovary Cancer and Drug-Response.
Journal: Cancers
Published: July 09, 2020
Last Updated: 09/26/2026